Jens Jørgen Elmer Christensen

Prof. Dr. Jens Jørgen Elmer Christensen

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
LØLauge Østergaard
Lauge Østergaard
MVMarianne Voldstedlund
Marianne Voldstedlund
NBNiels Eske Eske Bruun
Niels Eske Eske Bruun
HBHenning Bundgaard
Henning Bundgaard
KIKasper Iversen
Kasper Iversen
EFEmil Loldrup Fosbøl
Emil Loldrup Fosbøl
Background: Monitoring of microbiological cause of infective endocarditis (IE) remains key in the understanding of IE; however, data from large, unselected cohorts are sparse. We aimed to examine temporal changes, patient characteristics, and in‐hospital and long‐term mortality, according to microbiological cause in patients with IE from 2010 to 2017. Methods and Results: Linking Danish nationwide registries, we identified all patients with first‐time IE. In‐hospital and long‐term mortality rates were assessed according to microbiological cause and compared using multivariable adjusted logistic regression analysis and Cox proportional hazard analysis, respectively. A total of 4123 patients were included. Staphylococcus aureus was the most frequent cause (28.1%), followed by Streptococcus species (26.0%), Enterococcus species (15.5%), coagulase‐negative staphylococci (6.2%), and “other microbiological causes” (5.3%). Blood culture–negative IE was registered in 18.9%. The proportion of blood culture–negative IE declined during the study period, whereas no significant changes were seen for any microbiological cause. Patients with Enterococcus species were older and more often had a prosthetic heart valve compared with other causes. For Streptococcus species IE, in‐hospital and long‐term mortality (median follow‐up, 2.3 years) were 11.1% and 58.5%, respectively. Compared with Streptococcus species IE, the following causes were associated with a higher in‐hospital mortality: S aureus IE (odds ratio [OR], 3.48 [95% CI, 2.74–4.42]), Enterococcus species IE (OR, 1.48 [95% CI, 1.11–1.97]), coagulase‐negative staphylococci IE (OR, 1.79 [95% CI, 1.21–2.65]), “other microbiological cause” (OR, 1.47 [95% CI, 0.95–2.27]), and blood culture–negative IE (OR, 1.99 [95% CI, 1.52–2.61]); and the following causes were associated with higher mortality following discharge (median follow‐up, 2.9 years): S aureus IE (hazard ratio [HR], 1.39 [95% CI, 1.19–1.62]), Enterococcus species IE (HR, 1.31 [95% CI, 1.11–1.54]), coagulase‐negative staphylococci IE (HR, 1.07 [95% CI, 0.85–1.36]), “other microbiological cause” (HR, 1.45 [95% CI, 1.13–1.85]), and blood culture–negative IE (HR, 1.05 [95% CI, 0.89–1.25]). Conclusions: This nationwide study showed that S aureus was the most frequent microbiological cause of IE, followed by Streptococcus species and Enterococcus species. Patients with S aureus IE had the highest in‐hospital mortality .

24 May 2011 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
HMHossein Mirhendi
Hossein Mirhendi
BBB. Bruun
B. Bruun
HSH. C. Schønheyder
H. C. Schønheyder
JCJens Jørgen Elmer Christensen
Jens Jørgen Elmer Christensen
KFK. Fuursted
K. Fuursted
Maiken ArendrupMaiken Arendrup
Maiken Arendrup

1 October 2013 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
DBDana Bailey
Dana Bailey
EDEleftherios P Diamandis
Eleftherios P Diamandis
Gilbert GREUBGilbert GREUB
Gilbert GREUB
Susan PoutanenSusan Poutanen
Susan Poutanen
JCJens Jørgen Elmer Christensen
Jens Jørgen Elmer Christensen
MKMarkus Kostrzew
Markus Kostrzew
Although mass spectrometry is making its mark on all facets of clinical laboratory medicine, arguably no field is witnessing its impact more than clinical microbiology. The application of MALDI-TOF mass spectrometry (MALDI-TOF MS) to microbial identification is revolutionizing clinical microbiology by providing rapid identification with minimal sample preparation at a potential savings in costs. Across the globe, the degree of implementation of MALDI-TOF MS varies markedly. In Canada, Australia, and much of Europe, MALDI platforms are in routine use in clinical microbiology, whereas the US Food and Drug Administration has yet to provide clinical clearance. In this Q&A, 4 experts from across the globe with first-hand experience implementing MALDI-TOF MS in the microbiology laboratory provide insight into what this technology can and cannot provide, what it takes to bring it in house, and what direction it takes us in the future. The application of MALDI-TOF MS to the diagnosis of microbial infections has been touted as a revolution in clinical microbiology. However, no technology is without its pitfalls. Can you please describe what you feel are the greatest strengths and limitations of MALDI-TOF MS? Gilbert Greub: When it is used to identify bacterial strains and fungi, the main strengths of MALDI-TOF MS are the rapidity of the technique (<10 min), its low cost in terms of reagents and technician processing time [<2 Euros (95% accuracy at the species level. One of the most important limitations of this technique is its relatively low analytical sensitivity (about 105–106 bacteria/well). Thus, the accuracy of the identification is increased when the identification is done on a colony grown on agar or on a blood culture pellet, i.e., after a culture-based amplification step. Consequently, MALDI-TOF MS is not a tool currently suitable to detect …

21 January 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
CJChristian Salgård Jensen
Christian Salgård Jensen
KIKatrine Højholt Iversen
Katrine Højholt Iversen
RDRimtas Dargis
Rimtas Dargis
PSPatricia Shewmaker
Patricia Shewmaker
SRSimon Rasmussen
Simon Rasmussen
XNXiaohui Chen Nielsen
Xiaohui Chen Nielsen
A correct identification of Streptococcus pseudopneumoniae is a prerequisite for investigating the clinical impact of the bacterium. The identification has traditionally relied on phenotypic methods. However, these phenotypic traits have been shown to be unreliable, with some S. pseudopneumoniae giving conflicting results. Therefore, sequence based identification methods have increasingly been used for identification of S. pseudopneumoniae. In this study we used 64 S. pseudopneumoniae strains, 59 S. pneumoniae strains, 23 S. mitis strains, 25 S. oralis strains, seven S. infantis, and one S. peroris to test the capability of three single genes (rpoB, gyrB, recA), two MLSA schemes, the SNP based phylogeny tool CSI phylogeny, a k-mer based identification method (KmerFinder), Average Nucleotide Identity using fastANI and core genome analysis to identify S. pseudopneumoniae. Core genome analysis and CSI phylogeny were able to cluster all strains into distinct clusters related to their respective species. It was not possible to identify all S. pseudopneumoniae correctly using only one of the single genes. The MLSA schemes were unable to identify some of the S. pseudopneumoniae strains, and some strains could be misidentified. KmerFinder identified all S. pseudopneumoniae strains but misidentified one S. mitis strain as S. pseudopneumoniae and fastANI could differentiate between S. pseudopneumoniae and S. pneumoniae using an ANI cut-off of 96%.

27 September 2023 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Open access
BCBrian I Choi
Brian I Choi
AEAdriana Ene
Adriana Ene
JDJingjie Du
Jingjie Du
GJGenevieve Johnson
Genevieve Johnson
CPCatherine Putonti
Catherine Putonti
AWAlan J Wolfe
Alan J Wolfe
Average nucleotide identity analysis, based on whole genome sequences of 115 strains previously identified as Aerococcus urinae , an emerging uropathogen, discriminates at least six unique genomic taxa. The whole genome analysis affords clearer species boundaries over 16S rRNA gene sequencing and traditional phenotypic approaches for the identification and phylogenetic organization of Aerococcus species. The newly described species can be differentiated by matrix-assisted laser desorption ionization time-of-flight analysis of protein signatures. We propose the emendation of the description of A. urinae (type strain ATCC 51268T = CCUG 34223T=NCFB 2893) and the names of Aerococcus tenax sp. nov. (ATCC TSD-302T = DSM 115700T = CCUG 76531T=NR-58630T), Aerococcus mictus sp. nov. (ATCC TSD-301T = DSM 115699T = CCUG 76532T=NR-58629T), and Aerococcus loyolae sp. nov. (ATCC TSD-300T = DSM 115698T = CCUG 76533T=NR-58628T) for three of the newly identified genomic taxa.

1 July 1990 in APMIS
Verified
Journal Article
Closed access
PDF file
JCJens Jørgen Elmer Christensen
Jens Jørgen Elmer Christensen
JKJ. Keiding
J. Keiding
BBB. Bruun
B. Bruun